The DOI matches its Crossref record; 268 of the 268 references it cites were found in a registry or an index.
Insulin resistance and cardiovascular disease
Open accessAbstract
Insulin resistance (IR) and cardiovascular disease (CVD) represent two universal public health hazards, especially in today’s Western societies. A causal-effect relationship has been established that links IR with CVD. The mediating mechanisms are perplexing, under ongoing, rigorous investigation and remain to be fully elucidated. IR is a condition encompassing hyperglycemia and compensatory hyperinsulinemia. It occurs when insulin is not capable of exerting its maximum effects on target tissues, including skeletal muscles, liver and adipose tissue. This alteration of insulin signaling pathways results in the development of cardiometabolic disorders, including obesity, dyslipidemia, low-grade inflammation, endothelial dysfunction and hypertension, all of which are predisposing factors for atherosclerosis and CVD. The management of IR can be achieved through dietary modifications, the inclusion of regular exercise routines in everyday life, pharmacological agents and other interventions tailored to each individual patient’s needs. It is important to underline though that, although various antidiabetic drugs that may improve IR are available, no medications are as yet specifically approved for the treatment of IR. This narrative review will focus on the current scientific and clinical evidence pertaining to IR, the mechanisms connecting IR with CVD, as well as plausible strategies for a holistic, personalized approach for IR management.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association
Virani, S. S., Alonso, A., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Delling, F. N., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000757 · Cited by 9,175
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Xu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319451 · Cited by 6,760
Chen, X., Xiu, M., Xing, J., Yu, S., Min, D., & Guo, F. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479439 · Cited by 5,742
De Cillà, S. D., Farruggio, S., Vujosevic, S., Raina, G., Filippini, D., Gatti, V., Clemente, N., Mary, D., Vezzola, D., Casini, G., et al. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479441 · Cited by 5,136
Inflammation and insulin resistance
Shoelson, S. E. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29069 · Cited by 4,769
Obesity induces a phenotypic switch in adipose tissue macrophage polarization
Lumeng, C. N., Bodzin, J. L., & Saltiel, A. R. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29881 · Cited by 4,664
Adipokines in inflammation and metabolic disease
Ouchi, N., Parker, J. L., Lugus, J. J., & Walsh, K. (2011) · Nature Reviews Immunology · doi:10.1038/nri2921 · Cited by 4,625
Nitric oxide synthases: structure, function and inhibition
ALDERTON, W. K., COOPER, C. E., & KNOWLES, R. G. (2001) · Biochemical Journal · doi:10.1042/bj3570593 · Cited by 4,110
Gupta, A., & Uribarri, J. (2016) · Hormone Research in Paediatrics · doi:10.1159/000444053 · Cited by 4,006
The Global Epidemic of the Metabolic Syndrome
Saklayen, M. G. (2018) · Current Hypertension Reports · doi:10.1007/s11906-018-0812-z · Cited by 3,990 · cited 1×
“IR, which is closely related to metabolic syndrome (MetS), has been associated with the so-called Western lifestyle, characterized by high-calorie food consumption, limited physical activity and excessive stress.(3) IR is a clinical condition in which tissues sensitive to insulin, namely skeletal and cardiac muscle, a…”
BackgroundEstruch, R., Ros, E., Salas-Salvadó, J., Covas, M.-I., Corella, D., Arós, F., Gómez-Gracia, E., Ruiz-Gutiérrez, V., Fiol, M., Lapetra, J., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1800389 · Cited by 3,616
The Metabolic Syndrome and Cardiovascular Risk
Mottillo, S., Filion, K. B., Genest, J., Joseph, L., Pilote, L., Poirier, P., Rinfret, S., Schiffrin, E. L., & Eisenberg, M. J. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.05.034 · Cited by 3,009
Zelniker, T. A., Wiviott, S. D., Raz, I., Im, K., Goodrich, E. L., Bonaca, M. P., Mosenzon, O., Kato, E. T., Cahn, A., Furtado, R. H. M., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(18)32590-x · Cited by 2,845
Association between insulin resistance and the development of cardiovascular disease
Ormazabal, V., Nair, S., Elfeky, O., Aguayo, C., Salomon, C., & Zuñiga, F. A. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0762-4 · Cited by 2,280
Subcutaneous and visceral adipose tissue: Structural and functional differences
Ibrahim, M. M. (2010) · Obesity Reviews · doi:10.1111/j.1467-789x.2009.00623.x · Cited by 2,238
Armstrong, M. J., Gaunt, P., Aithal, G. P., Barton, D., Hull, D., Parker, R., Hazlehurst, J. M., Guo, K., Abouda, G., Aldersley, M. A., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00803-x · Cited by 2,203
Macrophage-specific PPARγ controls alternative activation and improves insulin resistance
Odegaard, J. I., Ricardo-Gonzalez, R. R., Goforth, M. H., Morel, C. R., Subramanian, V., Mukundan, L., Eagle, A. R., Vats, D., Brombacher, F., Ferrante, A. W., et al. (2007) · Nature · doi:10.1038/nature05894 · Cited by 2,107
Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes
Esser, N., Legrand-Poels, S., Piette, J., Scheen, A. J., & Paquot, N. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.04.006 · Cited by 1,981
Immunity and Inflammation in Atherosclerosis
Wolf, D., & Ley, K. (2019) · Circulation Research · doi:10.1161/circresaha.118.313591 · Cited by 1,697
The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective
Mahmood, S. S., Levy, D., Vasan, R. S., & Wang, T. J. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61752-3 · Cited by 1,622 · cited 1×
“For example, the Framingham Heart Study (FHS) and later associated studies have demonstrated a correlation between abnormal circulating cholesterol levels and CVD for more than half a century;(112,113) setting the foundation for determining certain risk profiles and scores, including the well-known Framingham Risk Sco…”
BackgroundSutton, E. F., Beyl, R., Early, K. S., Cefalu, W. T., Ravussin, E., & Peterson, C. M. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.04.010 · Cited by 1,531
Association of Hypoadiponectinemia With Coronary Artery Disease in Men
Kumada, M., Kihara, S., Sumitsuji, S., Kawamoto, T., Matsumoto, S., Ouchi, N., Arita, Y., Okamoto, Y., Shimomura, I., Hiraoka, H., et al. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000048856.22331.50 · Cited by 1,420
Triglycerides and cardiovascular disease
Nordestgaard, B. G., & Varbo, A. (2014) · The Lancet · doi:10.1016/s0140-6736(14)61177-6 · Cited by 1,419
Cardiac Energy Metabolism in Heart Failure
Lopaschuk, G. D., Karwi, Q. G., Tian, R., Wende, A. R., & Abel, E. D. (2021) · Circulation Research · doi:10.1161/circresaha.121.318241 · Cited by 1,373
Oxidative Stress in Atherosclerosis
Kattoor, A. J., Pothineni, N. V. K., Palagiri, D., & Mehta, J. L. (2017) · Current Atherosclerosis Reports · doi:10.1007/s11883-017-0678-6 · Cited by 1,266
Impact of intermittent fasting on health and disease processes
Mattson, M. P., Longo, V. D., & Harvie, M. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2016.10.005 · Cited by 1,187
Inflammation and insulin resistance
de Luca, C., & Olefsky, J. M. (2008) · FEBS Letters · doi:10.1016/j.febslet.2007.11.057 · Cited by 1,161
Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients
Ferrannini, E., Muscelli, E., Frascerra, S., Baldi, S., Mari, A., Heise, T., Broedl, U. C., & Woerle, H.-J. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72227 · Cited by 1,134
Reactive oxygen species: from health to disease
Brieger, K., Schiavone, S., Miller Jr., F. J., & Krause, K.-H. (2012) · Swiss Medical Weekly · doi:10.4414/smw.2012.13659 · Cited by 1,133
Pioglitazone after Ischemic Stroke or Transient Ischemic Attack
Kernan, W. N., Viscoli, C. M., Furie, K. L., Young, L. H., Inzucchi, S. E., Gorman, M., Guarino, P. D., Lovejoy, A. M., Peduzzi, P. N., Conwit, R., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1506930 · Cited by 1,124
Advanced Glycation End Products and Oxidative Stress in Type 2 Diabetes Mellitus
Nowotny, K., Jung, T., Höhn, A., Weber, D., & Grune, T. (2015) · Biomolecules · doi:10.3390/biom5010194 · Cited by 1,095 · cited 17×
“These alterations may actually represent some of the mechanisms responsible for the development of CVD.”
BackgroundInfluentialFesta, A., D’Agostino, R., Tracy, R. P., & Haffner, S. M. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1131 · Cited by 1,057
Cusi, K., Orsak, B., Bril, F., Lomonaco, R., Hecht, J., Ortiz-Lopez, C., Tio, F., Hardies, J., Darland, C., Musi, N., et al. (2016) · Annals of Internal Medicine · doi:10.7326/m15-1774 · Cited by 1,024
Sharrett, A. R., Ballantyne, C. M., Coady, S. A., Heiss, G., Sorlie, P. D., Catellier, D., & Patsch, W. (2001) · Circulation · doi:10.1161/hc3501.095214 · Cited by 944
Inflammation and Lipid Signaling in the Etiology of Insulin Resistance
Glass, C. K., & Olefsky, J. M. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.001 · Cited by 935
Insulin resistance: review of the underlying molecular mechanisms
Yaribeygi, H., Farrokhi, F. R., Butler, A. E., & Sahebkar, A. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.27603 · Cited by 929
Obesity: definition, comorbidities, causes, and burden.
Apovian, C. M. (2016) · PubMed · Cited by 898
MCP-1: Function, regulation, and involvement in disease
Singh, S., Anshita, D., & Ravichandiran, V. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107598 · Cited by 883
DeFronzo, R. A. (2010) · Diabetologia · doi:10.1007/s00125-010-1684-1 · Cited by 879
Research Progress on the Relationship between Atherosclerosis and Inflammation
Zhu, Y., Xian, X., Wang, Z., Bi, Y., Chen, Q., Han, X., Tang, D., & Chen, R. (2018) · Biomolecules · doi:10.3390/biom8030080 · Cited by 872
Oxidative Stress in Cardiovascular Diseases: Still a Therapeutic Target?
Senoner, T., & Dichtl, W. (2019) · Nutrients · doi:10.3390/nu11092090 · Cited by 868
Metabolic Syndrome and Insulin Resistance: Underlying Causes and Modification by Exercise Training
Roberts, C. K., Hevener, A. L., & Barnard, R. J. (2013) · Comprehensive Physiology · doi:10.1002/cphy.c110062 · Cited by 831
Roles for chemokines in liver disease
Marra, F., & Tacke, F. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.06.043 · Cited by 829 · cited 1×
“CCL2 seems to exert a direct effect on adipocytes, decreasing insulin-regulated glucose uptake and altering the expression of certain adipogenic genes.(71) Leptin is a peptide produced and secreted from WAT and mediates appetite and feeding behavior.”
BackgroundHarvie, M. N., Pegington, M., Mattson, M. P., Frystyk, J., Dillon, B., Evans, G., Cuzick, J., Jebb, S. A., Martin, B., Cutler, R. G., et al. (2011) · International Journal of Obesity · doi:10.1038/ijo.2010.171 · Cited by 804
SGLT2 inhibitors: mechanisms of cardiovascular benefit beyond glycaemic control
Cowie, M. R., & Fisher, M. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-020-0406-8 · Cited by 784
Biochemical and cellular properties of insulin receptor signalling
Haeusler, R. A., McGraw, T. E., & Accili, D. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.89 · Cited by 739 · cited 2×
“It exerts its function during postprandial hyperglycemia, mediates glucose uptake and storage in muscle cells and adipocytes, promotes glycogen synthesis, inhibits lipolysis and decreases gluconeogenesis in hepatocytes.(1,6,30) Its function is exerted through binding to insulin receptors.”
BackgroundMechanisms of insulin resistance in obesity
Ye, J. (2013) · Frontiers of Medicine · doi:10.1007/s11684-013-0262-6 · Cited by 699 · cited 2×
“Insulin resistance and an excess lipid pool also trigger inflammatory signaling pathways like c-Jun N-terminal kinase (JNK), IjBa kinase b and nuclear factor KB (NF-kB), resulting in the production of proinflammatory cytokines, such as TNF-a, IL-6, IL-1b, PAI-1, MCP-1, leptin and resistin, and a reduction of adiponect…”
BackgroundRuegsegger, G. N., & Booth, F. W. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a029694 · Cited by 690
Palmer, S. C., Tendal, B., Mustafa, R. A., Vandvik, P. O., Li, S., Hao, Q., Tunnicliffe, D., Ruospo, M., Natale, P., Saglimbene, V., et al. (2021) · BMJ · doi:10.1136/bmj.m4573 · Cited by 679
Vitamin D supplementation and prevention of type 2 diabetes
Pittas, A. G., Dawson-Hughes, B., Sheehan, P., Ware, J. H., Knowler, W. C., Aroda, V. R., Brodsky, I., Ceglia, L., Chadha, C., Chatterjee, R., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1900906 · Cited by 673
Insulin resistance: definition and consequences
Lebovitz, H. (2001) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2001-18576 · Cited by 664
Metabolites as regulators of insulin sensitivity and metabolism
Yang, Q., Vijayakumar, A., & Kahn, B. B. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0044-8 · Cited by 663
Laaksonen, D. E., Lakka, H.-M., Salonen, J. T., Niskanen, L. K., Rauramaa, R., & Lakka, T. A. (2002) · Diabetes Care · doi:10.2337/diacare.25.9.1612 · Cited by 657 · cited 1×
“Time spent on physical activity is another determinant, with 60 minutes a week of leisure-time vigorous physical activity significantly reducing rates of MetS among unfit and fit men.(189) A metaanalysis of the impact of structured exercise programs on IR in 846 diabetic patients demonstrated clear evidence for the ef…”
BackgroundInsulin effects in muscle and adipose tissue
Dimitriadis, G., Mitrou, P., Lambadiari, V., Maratou, E., & Raptis, S. A. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(11)70014-6 · Cited by 649
Nitric Oxide and Endothelial Dysfunction
Cyr, A. R., Huckaby, L. V., Shiva, S. S., & Zuckerbraun, B. S. (2020) · Critical Care Clinics · doi:10.1016/j.ccc.2019.12.009 · Cited by 640
Physiology and role of irisin in glucose homeostasis
Perakakis, N., Triantafyllou, G. A., Fernández-Real, J. M., Huh, J. Y., Park, K. H., Seufert, J., & Mantzoros, C. S. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.221 · Cited by 621
Interleukin-1 Beta as a Target for Atherosclerosis Therapy
Libby, P. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.09.028 · Cited by 619
Bethel, M. A., Patel, R. A., Merrill, P., Lokhnygina, Y., Buse, J. B., Mentz, R. J., Pagidipati, N. J., Chan, J. C., Gustavson, S. M., Iqbal, N., et al. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30412-6 · Cited by 599
Endothelial Dysfunction and Hypertension
Konukoglu, D., & Uzun, H. (2016) · Advances in Experimental Medicine and Biology · doi:10.1007/5584_2016_90 · Cited by 594
Oxidative stress and inflammatory markers in prediabetes and diabetes.
Luc, K., Schramm‐Luc, A., Guzik, T. J., & Mikolajczyk, T. P. (2019) · PubMed · doi:10.26402/jpp.2019.6.01 · Cited by 587
SGLT2 inhibitors and GLP-1 receptor agonists: established and emerging indications
Brown, E., Heerspink, H. J. L., Cuthbertson, D. J., & Wilding, J. P. H. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00536-5 · Cited by 581
Adipokines: A link between obesity and cardiovascular disease
Nakamura, K., Fuster, J. J., & Walsh, K. (2014) · Journal of Cardiology · doi:10.1016/j.jjcc.2013.11.006 · Cited by 578
Molecular pathways associated with oxidative stress in diabetes mellitus
Ighodaro, O. M. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.09.058 · Cited by 555
Pathophysiology of Diabetic Dyslipidemia
Hirano, T. (2018) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.rv17023 · Cited by 552 · cited 1×
“The sdLDL-C particles are particularly proatherogenic for various reasons: their smaller size facilitates their entrance into the vessel walls; they have impaired affinity with the LDL-C receptor; a longer half-life and lower resistance to oxidation.(127,128)”
BackgroundHyperinsulinemia, Hyperglycemia, and Impaired Hemostasis: The Framingham Offspring Study
Meigs, J. B., Mittleman, M. A., Nathan, D. M., Tofler, G. H., Singer, D. E., Murphy-Sheehy, P. M., Lipinska, I., D'Agostino, R. B., & Wilson, P. W. F. (2000) · JAMA · doi:10.1001/jama.283.2.221 · Cited by 538
Godo, S., & Shimokawa, H. (2017) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.117.309813 · Cited by 536
Insulin Resistance and Atherosclerosis: Implications for Insulin-Sensitizing Agents
Di Pino, A., & DeFronzo, R. A. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00141 · Cited by 535
Gut microbiota and metabolic syndrome
Festi, D., Schiumerini, R., Eusebi, L. H., Marasco, G., Taddia, M., & Colecchia, A. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i43.16079 · Cited by 534 · cited 1×
“However, evidence to date is not convincing.(180) Vitamin D deficiency characterizes patients with T1D and T2D, and numerous observational and preclinical trials underline the importance of this nutrient in their pathogenesis; 70% of prediabetic patients with hypovitaminosis D eventually become diabetic.”
BackgroundWu, L., & Parhofer, K. G. (2014) · Metabolism · doi:10.1016/j.metabol.2014.08.010 · Cited by 516
Hoogeveen, R. C., Gaubatz, J. W., Sun, W., Dodge, R. C., Crosby, J. R., Jiang, J., Couper, D., Virani, S. S., Kathiresan, S., Boerwinkle, E., et al. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.303284 · Cited by 507
Jørgensen, A. B., Frikke-Schmidt, R., West, A. S., Grande, P., Nordestgaard, B. G., & Tybjærg-Hansen, A. (2013) · European Heart Journal · doi:10.1093/eurheartj/ehs431 · Cited by 501
Insulin Resistance, Obesity and Lipotoxicity
Yazıcı, D., & Sezer, H. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-48382-5_12 · Cited by 499
Exercise and insulin resistance in type 2 diabetes mellitus: A systematic review and meta-analysis
Sampath Kumar, A., Maiya, A. G., Shastry, B. A., Vaishali, K., Ravishankar, N., Hazari, A., Gundmi, S., & Jadhav, R. (2019) · Annals of Physical and Rehabilitation Medicine · doi:10.1016/j.rehab.2018.11.001 · Cited by 469
GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects
Zhao, X., Wang, M., Wen, Z., Lu, Z., Cui, L., Fu, C., Xue, H., Liu, Y., & Zhang, Y. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.721135 · Cited by 463
The impact of insulin resistance on the kidney and vasculature
Artunc, F., Schleicher, E., Weigert, C., Fritsche, A., Stefan, N., & Häring, H.-U. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.145 · Cited by 462
Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis
Armstrong, M. J., Hull, D., Guo, K., Barton, D., Hazlehurst, J. M., Gathercole, L. L., Nasiri, M., Yu, J., Gough, S. C., Newsome, P. N., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.08.038 · Cited by 456
Ding, X., Wang, X., Wu, J., Zhang, M., & Cui, M. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01268-9 · Cited by 454
Insulin signaling in health and disease
Saltiel, A. R. (2021) · Journal of Clinical Investigation · doi:10.1172/jci142241 · Cited by 446
Visceral fat and insulin resistance — causative or correlative?
Frayn, K. N. (2000) · British Journal of Nutrition · doi:10.1017/s0007114500000982 · Cited by 445
The Emerging Role of Branched-Chain Amino Acids in Insulin Resistance and Metabolism
Yoon, M.-S. (2016) · Nutrients · doi:10.3390/nu8070405 · Cited by 430
Mitochondrial dysfunction in type 2 diabetes mellitus: an organ-based analysis
Pinti, M. V., Fink, G. K., Hathaway, Q. A., Durr, A. J., Kunovac, A., & Hollander, J. M. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00314.2018 · Cited by 427
Preis, S. R., Massaro, J. M., Robins, S. J., Hoffmann, U., Vasan, R. S., Irlbeck, T., Meigs, J. B., Sutherland, P., D'Agostino Sr, R. B., O'Donnell, C. J., et al. (2010) · Obesity · doi:10.1038/oby.2010.59 · Cited by 412
The mode of action of thiazolidinediones
Hauner, H. (2002) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.249 · Cited by 411
Katzmarzyk, P. T., Church, T. S., & Blair, S. N. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.10.1092 · Cited by 408
Insulin resistance in children: Consensus, perspective, and future directions
Levy-Marchal, C., Arslanian, S., Cutfield, W., Sinaiko, A., Druet, C., Marcovecchio, M. L., & Chiarelli, F. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1047 · Cited by 405
Gast, K. B., Tjeerdema, N., Stijnen, T., Smit, J. W. A., & Dekkers, O. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052036 · Cited by 403
Life history of eNOS: partners and pathways
DUDZINSKI, D., & MICHEL, T. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.03.023 · Cited by 400
Thiazolidinediones: the forgotten diabetes medications
Lebovitz, H. E. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1270-y · Cited by 388
The RAGE axis: A fundamental mechanism signaling danger to the vulnerable vasculature
Yan, S. F., Ramasamy, R., & Schmidt, A. M. (2010) · Circulation Research · doi:10.1161/circresaha.109.212217 · Cited by 381
Metabolic Syndrome, Obesity, and Mortality
Katzmarzyk, P. T., Church, T. S., Janssen, I., Ross, R., & Blair, S. N. (2005) · Diabetes Care · doi:10.2337/diacare.28.2.391 · Cited by 378
Inflammation in atherosclerosis
Taleb, S. (2016) · Archives of Cardiovascular Diseases · doi:10.1016/j.acvd.2016.04.002 · Cited by 375
Plasminogen activator inhibitor-1, inflammation, obesity, insulin resistance and vascular risk
Juhan-Vague, I., Alessi, M.-C., Mavri, A., & Morange, P. E. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00279.x · Cited by 371 · cited 1×
“VAT secretes PAI-1, thus explaining its connection with obesity-related insulin resistance.(64,65) The PAI-1 genotype seems to affect the vascular risk linked to hyperinsulinemia.”
BackgroundAthyros, V. G., Doumas, M., Imprialos, K. P., Stavropoulos, K., Georgianou, E., Katsimardou, A., & Karagiannis, A. (2018) · Hormones · doi:10.1007/s42000-018-0014-8 · Cited by 367
Chang, Y., Chang, D., Lin, K., Shin, S., & Lee, Y. (2011) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1201 · Cited by 356
Obesity, Polycystic Ovary Syndrome, and Infertility: A New Avenue for GLP-1 Receptor Agonists
Cena, H., Chiovato, L., & Nappi, R. E. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa285 · Cited by 356
Genetics of Insulin Resistance and the Metabolic Syndrome
Brown, A. E., & Walker, M. (2016) · Current Cardiology Reports · doi:10.1007/s11886-016-0755-4 · Cited by 348
Insulin and its receptor: structure, function and evolution
De Meyts, P. (2004) · BioEssays · doi:10.1002/bies.20151 · Cited by 345
The morphology and metabolism of intraabdominal adipose tissue in men
Mårin, P., Andersson, B., Ottosson, M., Olbe, L., Chowdhury, B., Kvist, H., Holm, G., Sjöström, L., & Björntorp, P. (1992) · Metabolism · doi:10.1016/0026-0495(92)90016-4 · Cited by 336
Duran, E. K., Aday, A. W., Cook, N. R., Buring, J. E., Ridker, P. M., & Pradhan, A. D. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.02.059 · Cited by 334
Tzanavari, T., Giannogonas, P., & Karalis, K. P. (2010) · Current Directions in Autoimmunity · doi:10.1159/000289203 · Cited by 322
Kahleova, H., Matoulek, M., Malinska, H., Oliyarnik, O., Kazdova, L., Neskudla, T., Skoch, A., Hajek, M., Hill, M., Kahle, M., et al. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2010.03209.x · Cited by 312 · cited 3×
“04).(170) The reduction of IR may be attributed to the concurrently observed weight loss, visceral fat loss and the amelioration of oxidative stress markers, as the beneficial adaptations in these factors were also greater in the experimental group.”
BackgroundMethodInfluentialMisra, A., & Vikram, N. K. (2003) · Nutrition · doi:10.1016/s0899-9007(02)01003-1 · Cited by 307
Regulation of glucose and lipid metabolism in health and disease
Chen, L., Chen, X.-W., Huang, X., Song, B.-L., Wang, Y., & Wang, Y. (2019) · Science China Life Sciences · doi:10.1007/s11427-019-1563-3 · Cited by 306
70-year legacy of the Framingham Heart Study
Andersson, C., Johnson, A. D., Benjamin, E. J., Levy, D., & Vasan, R. S. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0202-5 · Cited by 305
Assessment of preferred methods to measure insulin resistance in Asian patients with hypertension
Minh, H. V., Tien, H. A., Sinh, C. T., Thang, D. C., Chen, C., Tay, J. C., Siddique, S., Wang, T., Sogunuru, G. P., Chia, Y., et al. (2021) · The Journal of Clinical Hypertension · doi:10.1111/jch.14155 · Cited by 305
Autophagy in ovary and polycystic ovary syndrome: role, dispute and future perspective
Kumariya, S., Ubba, V., Jha, R. K., & Gayen, J. R. (2021) · Autophagy · doi:10.1080/15548627.2021.1938914 · Cited by 305
SGLT2 Inhibitors: A Review of Their Antidiabetic and Cardioprotective Effects
Tentolouris, A., Vlachakis, P., Tzeravini, E., Eleftheriadou, I., & Tentolouris, N. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16162965 · Cited by 300
Associations of vitamin D with insulin resistance, obesity, type 2 diabetes, and metabolic syndrome
Wimalawansa, S. J. (2018) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.09.017 · Cited by 300
GLP-1 receptor agonists (GLP-1RAs): cardiovascular actions and therapeutic potential
Ma, X., Liu, Z., Ilyas, I., Little, P. J., Kamato, D., Sahebka, A., Chen, Z., Luo, S., Zheng, X., Weng, J., et al. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.59965 · Cited by 299
Regulation of obesity and insulin resistance by nitric oxide
Sansbury, B. E., & Hill, B. G. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.05.016 · Cited by 274 · cited 1×
“NOS1-derived NO is related to appetite stimulation and hyperphagia.(149) Nevertheless, glucose metabolism and insulin-stimulated NO production share common signaling pathways, underpinning a coupling between insulin’s metabolic and vascular effects.”
BackgroundMediterranean diet nutrients to turn the tide against insulin resistance and related diseases
Mirabelli, M., Chiefari, E., Arcidiacono, B., Corigliano, D. M., Brunetti, F. S., Maggisano, V., Russo, D., Foti, D. P., & Brunetti, A. (2020) · Nutrients · doi:10.3390/nu12041066 · Cited by 272 · cited 1×
“Its structure provides polyunsaturated fatty acids, anthocyanins, resveratrol and polyphenols, all of which contribute to a decrease of inflammation and lipotoxicity, an increase of insulin-dependent glucose uptake, neuroprotection, improvement of hyperinsulinemia and hyperandrogenemia, and even mediate gene transcrip…”
BackgroundReducing insulin resistance with metformin: the evidence today
Giannarelli, R., Aragona, M., Coppelli, A., & Del Prato, S. (2003) · Diabetes & Metabolism · doi:10.1016/s1262-3636(03)72785-2 · Cited by 269
Adropin Deficiency Is Associated With Increased Adiposity and Insulin Resistance
Ganesh‐Kumar, K., Zhang, J., Gao, S., Rossi, J., McGuinness, O. P., Halem, H. H., Culler, M. D., Mynatt, R. L., & Butler, A. A. (2012) · Obesity · doi:10.1038/oby.2012.31 · Cited by 262
Exercise and type 2 diabetes: focus on metabolism and inflammation
Karstoft, K., & Pedersen, B. K. (2016) · Immunology & Cell Biology · doi:10.1038/icb.2015.101 · Cited by 260
New markers of insulin resistance in polycystic ovary syndrome
Polak, K., Czyzyk, A., Simoncini, T., & Meczekalski, B. (2017) · Journal of Endocrinological Investigation · doi:10.1007/s40618-016-0523-8 · Cited by 256
Fetuin B is a secreted hepatocyte factor linking steatosis to impaired glucose metabolism
Meex, R. C., Hoy, A. J., Morris, A., Brown, R. D., Lo, J. C. Y., Burke, M., Goode, R. J. A., Kingwell, B. A., Kraakman, M. J., Febbraio, M. A., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.09.023 · Cited by 255
Herman, R., Kravos, N. A., Jensterle, M., Janež, A., & Dolžan, V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031264 · Cited by 254
Aroda, V. R. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13162 · Cited by 253
White adipose tissue dysfunction in obesity and aging
Reyes-Farias, M., Fos-Domenech, J., Serra, D., Herrero, L., & Sánchez-Infantes, D. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114723 · Cited by 250
Wang, F., Han, L., & Hu, D. (2017) · Clinica Chimica Acta · doi:10.1016/j.cca.2016.11.009 · Cited by 247
Hepatic Insulin Clearance: Mechanism and Physiology
Najjar, S. M., & Perdomo, G. (2019) · Physiology · doi:10.1152/physiol.00048.2018 · Cited by 246
Hypertriglyceridemia and atherosclerosis
Peng, J., Luo, F., Ruan, G., Peng, R., & Li, X. (2017) · Lipids in Health and Disease · doi:10.1186/s12944-017-0625-0 · Cited by 245
Nutritional ketosis for weight management and reversal of metabolic syndrome
Gershuni, V. M., Yan, S. L., & Medici, V. (2018) · Current Nutrition Reports · doi:10.1007/s13668-018-0235-0 · Cited by 239
Metabolic Syndrome: Focus on Dyslipidemia
Ginsberg, H. N., Zhang, Y., & Hernandez‐Ono, A. (2006) · Obesity · doi:10.1038/oby.2006.281 · Cited by 228
Chapter 21 Interleukin‐6 and Insulin Resistance
Kim, J., Bachmann, R. A., & Chen, J. (2009) · Vitamins & Hormones · doi:10.1016/s0083-6729(08)00621-3 · Cited by 224
Manrique, C., Lastra, G., Gardner, M., & Sowers, J. R. (2009) · Medical Clinics of North America · doi:10.1016/j.mcna.2009.02.014 · Cited by 224
The role of interleukin‐6 in insulin resistance, body fat distribution and energy balance
Hoene, M., & Weigert, C. (2008) · Obesity Reviews · doi:10.1111/j.1467-789x.2007.00410.x · Cited by 217
Plasminogen activator inhibitor-1, adipose tissue and insulin resistance
Alessi, M.-C., Poggi, M., & Juhan-Vague, I. (2007) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32814e6d29 · Cited by 212 · cited 1×
“The PAI-1 genotype seems to affect the vascular risk linked to hyperinsulinemia.(66) A previous study also described a causality relationship between elevated PAI-1 plasma levels and coronary artery disease (CAD).”
BackgroundBiomarkers of insulin sensitivity and insulin resistance: Past, present and future
Park, S. E., Park, C.-Y., & Sweeney, G. (2015) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2015.1023429 · Cited by 203
Gao, S., McMillan, R. P., Zhu, Q., Lopaschuk, G. D., Hulver, M. W., & Butler, A. A. (2015) · Molecular Metabolism · doi:10.1016/j.molmet.2015.01.005 · Cited by 192
Nitric oxide and vascular insulin resistance
Wu, G., & Meininger, C. J. (2009) · BioFactors · doi:10.1002/biof.3 · Cited by 190
Mechanisms and Treatment of Dyslipidemia in Diabetes
Bahiru, E. M., Hsiao, R., Philipson, D. J., & Watson, K. E. (2021) · Current Cardiology Reports · doi:10.1007/s11886-021-01455-w · Cited by 183
Exercise and Insulin Resistance in Youth: A Meta-Analysis
Fedewa, M. V., Gist, N. H., Evans, E. M., & Dishman, R. K. (2014) · Pediatrics · doi:10.1542/peds.2013-2718 · Cited by 181
Velázquez-López, L., Santiago-Díaz, G., Nava-Hernández, J., Muñoz-Torres, A. V., Medina-Bravo, P., & Torres-Tamayo, M. (2014) · BMC Pediatrics · doi:10.1186/1471-2431-14-175 · Cited by 178
PAI‐1, progress in understanding the clinical problem and its aetiology
Iwaki, T., Urano, T., & Umemura, K. (2012) · British Journal of Haematology · doi:10.1111/j.1365-2141.2012.09074.x · Cited by 177
Pareek, M., Schauer, P. R., Kaplan, L. M., Leiter, L. A., Rubino, F., & Bhatt, D. L. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.12.014 · Cited by 177
The RISE Consortium, Nadeau, K. J., Hannon, T. S., Edelstein, S. L., Arslanian, S. A., Caprio, S., Leschek, E. W., Zeitler, P. S., Buchanan, T. A., Ehrmann, D. A., et al. (2018) · Diabetes Care · doi:10.2337/dc18-0787 · Cited by 176
Prevalence of insulin resistance in essential hypertension
Lind, L., Berne, C., & Lithell, H. (1995) · Journal of Hypertension · doi:10.1097/00004872-199512000-00012 · Cited by 176
Tejido adiposo: heterogeneidad celular y diversidad funcional
Esteve Ràfols, M. (2014) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2013.03.011 · Cited by 173
Microscopic Anatomy of the Human Islet of Langerhans
Veld, P. I. '., & Marichal, M. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-90-481-3271-3_1 · Cited by 172
Effect of Diet on Insulin Resistance in Polycystic Ovary Syndrome
Shang, Y., Zhou, H., Hu, M., & Feng, H. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa425 · Cited by 171
Empagliflozin: A Review in Type 2 Diabetes
Frampton, J. E. (2018) · Drugs · doi:10.1007/s40265-018-0937-z · Cited by 171
Botts, S. R., Fish, J. E., & Howe, K. L. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.787541 · Cited by 171
Kaze, A. D., Santhanam, P., Musani, S. K., Ahima, R., & Echouffo‐Tcheugui, J. B. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.016947 · Cited by 167
Adipose tissue: Cell heterogeneity and functional diversity
Esteve Ràfols, M. (2014) · Endocrinología y Nutrición (English Edition) · doi:10.1016/j.endoen.2014.02.001 · Cited by 166
Relationship between plasma plasminogen activator inhibitor 1 and insulin resistance
Bastard, J., Pi�roni, L., & Hainque, B. (2000) · Diabetes/Metabolism Research and Reviews · doi:10.1002/1520-7560(200005/06)16:3<192::aid-dmrr114>3.0.co;2-g · Cited by 166
Energy metabolism of white adipose tissue and insulin resistance in humans
Bódis, K. B., & Roden, M. (2018) · European Journal of Clinical Investigation · doi:10.1111/eci.13017 · Cited by 166
Pathophysiology of essential hypertension: an update
Saxena, T., Ali, A. O., & Saxena, M. (2018) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2018.1540301 · Cited by 166
Marson, E. C., Delevatti, R. S., Prado, A. K. G., Netto, N. D. S., & Kruel, L. F. M. (2016) · Preventive Medicine · doi:10.1016/j.ypmed.2016.10.020 · Cited by 164
Role of insulin and other related hormones in energy metabolism���A review
Qaid, M. M., & Abdelrahman, M. M. (2016) · Cogent Food & Agriculture · doi:10.1080/23311932.2016.1267691 · Cited by 161
GLP-1 receptor agonists versus metformin in PCOS: a systematic review and meta-analysis
Han, Y., Li, Y., & He, B. (2019) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2019.04.017 · Cited by 159
Heo, Y. J., Choi, S.-E., Jeon, J. Y., Han, S. J., Kim, D. J., Kang, Y., Lee, K. W., & Kim, H. J. (2019) · Journal of Diabetes Research · doi:10.1155/2019/4021623 · Cited by 158
Juhan-Vague, I., Alessi, M., & Morange, P. (2000) · PubMed · Cited by 157
Antushevich, H., & Wójcik, M. (2018) · Clinica Chimica Acta · doi:10.1016/j.cca.2018.05.012 · Cited by 154
Motahari-Tabari, N., Shirvani, M. A., Shirzad, M., Abdolmaleki, E. Y., & Teimourzadeh, M. (2014) · Global Journal of Health Science · doi:10.5539/gjhs.v7n1p115 · Cited by 150
Zhao, H., Xing, C., Zhang, J., & He, B. (2021) · Reproductive Health · doi:10.1186/s12978-021-01207-7 · Cited by 148
Effects of SGLT2 inhibitors and GLP-1 receptor agonists on renin-angiotensin-aldosterone system
Puglisi, S., Rossini, A., Poli, R., Dughera, F., Pia, A., Terzolo, M., & Reimondo, G. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.738848 · Cited by 143
Scisciola, L., Cataldo, V., Taktaz, F., Fontanella, R. A., Pesapane, A., Ghosh, P., Franzese, M., Puocci, A., Angelis, A. D., Sportiello, L., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.1008922 · Cited by 141
Organ protection by SGLT2 inhibitors: role of metabolic energy and water conservation
Marton, A., Kaneko, T., Kovalik, J., Yasui, A., Nishiyama, A., Kitada, K., & Titze, J. M. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-020-00350-x · Cited by 140
Zhou, M.-S., Schulman, I. H., & Raij, L. R. (2010) · Journal of Hypertension · doi:10.1097/hjh.0b013e3283340da8 · Cited by 139
Causal Effect of Plasminogen Activator Inhibitor Type 1 on Coronary Heart Disease
Song, C., Burgess, S., Eicher, J. D., O’Donnell, C. J., Johnson, A. D., Huang, J., Sabater‐Lleal, M., Asselbergs, F. W., Trégouët, D., Shin, S., et al. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.004918 · Cited by 139
Oxidative stress: an evolving definition
Ji, L. L., & Yeo, D. (2021) · Faculty Reviews · doi:10.12703/r/10-13 · Cited by 137
Li, S., Vandvik, P. O., Lytvyn, L., Guyatt, G. H., Palmer, S. C., Rodríguez‐Gutiérrez, R., Foroutan, F., Agoritsas, T., Siemieniuk, R. A. C., Walsh, M. W., et al. (2021) · BMJ · doi:10.1136/bmj.n1091 · Cited by 137
Wang, T., Li, M., Zeng, T., Hu, R., Xu, Y., Xu, M., Zhao, Z., Chen, Y., Wang, S., Lin, H., et al. (2022) · Diabetes Care · doi:10.2337/dc22-0202 · Cited by 137
Fruzzetti, F., Perini, D., Russo, M., Bucci, F., & Gadducci, A. (2017) · Gynecological Endocrinology · doi:10.1080/09513590.2016.1236078 · Cited by 135
Xu, L., & Ota, T. (2017) · Adipocyte · doi:10.1080/21623945.2017.1413516 · Cited by 134
Endothelial dysfunction in conduit arteries and in microcirculation. Novel therapeutic approaches
Tousoulis, D., Simopoulou, C., Παπαγεωργίου, Ν., Oikonomou, E. K., Hatzis, G., Siasos, G., Tsiamis, E. G., & Stefanadis, C. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.06.003 · Cited by 133
An Overview of the Role of Adipokines in Cardiometabolic Diseases
Farkhondeh, T., Llorens, S., Pourbagher‐Shahri, A. M., Ashrafizadeh, M., Talebi, M., Shakibaei, M., & Samarghandian, S. (2020) · Molecules · doi:10.3390/molecules25215218 · Cited by 133
GLP-1 receptor agonists and cardiovascular outcome trials: An update
Andrikou, E., Tsioufis, C. P., Andrikou, I., Leontsinis, I., Tousoulis, D. M., & Παπάνας, Ν. (2018) · Hellenic Journal of Cardiology · doi:10.1016/j.hjc.2018.11.008 · Cited by 127
Wei, Q., Xu, X., Guo, L., Li, J., & Li, L. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.635556 · Cited by 126
Indulekha, K., Anjana, R. M., Surendar, J., & Mohan, V. (2011) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2010.12.015 · Cited by 125
Pirro, V., Roth, K. D. W., Lin, Y., Willency, J. A., Milligan, P. L., Wilson, J. M., Ruotolo, G., Haupt, A., Newgard, C. B., & Duffin, K. L. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab722 · Cited by 125
The Role of Apelin–APJ System in Diabetes and Obesity
Li, C., Cheng, H., Adhikari, B. K., Wang, S., Yang, N., Liu, W., Sun, J., & Wang, Y. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.820002 · Cited by 124
Kullmann, S., Hummel, J., Wagner, R. J., Dannecker, C., Vosseler, A., Fritsche, L., Veit, R., Kantartzis, K., Machann, J., Birkenfeld, A. L., et al. (2021) · Diabetes Care · doi:10.2337/dc21-1136 · Cited by 123
Molecular Mechanisms of SGLT2 Inhibitor on Cardiorenal Protection
Hou, Y., Zheng, C., Yen, T., & Lu, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21217833 · Cited by 122
Andersson, C., Nayor, M. G., Tsao, C. W., Levy, D. A., & Vasan, R. S. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.01.059 · Cited by 120
Adipose tissue macrophages and their polarization in health and obesity
Catrysse, L., & Loo, G. (2018) · Cellular Immunology · doi:10.1016/j.cellimm.2018.03.001 · Cited by 116
Vasudevan, A. R., & Balasubramanyam, A. (2004) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2004.6.850 · Cited by 110
SGLT2-inhibitors; more than just glycosuria and diuresis
Fathi, A., Vickneson, K., & Singh, J. S. (2021) · Heart Failure Reviews · doi:10.1007/s10741-020-10038-w · Cited by 109
Role of visfatin in obesity-induced insulin resistance
Abdalla, M. M. I. (2022) · World Journal of Clinical Cases · doi:10.12998/wjcc.v10.i30.10840 · Cited by 109
C-Peptide: Much More Than a Byproduct of Insulin Biosynthesis
Marques, R. G., Fontaine, M. J., & Rogers, J. D. (2004) · Pancreas · doi:10.1097/00006676-200410000-00009 · Cited by 108
Role of Insulin in the Pathogenesis of Free Fatty Acid-Induced Insulin Resistance in Skeletal Muscle
Ye, J. (2007) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/187153007780059423 · Cited by 108
Monocyte chemotactic protein-1 and its role in insulin resistance
Sell, H., & Eckel, J. (2007) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3281338546 · Cited by 107
Mirr, M., Skrypnik, D., Bogdański, P., & Owecki, M. (2021) · Journal of Endocrinological Investigation · doi:10.1007/s40618-021-01608-2 · Cited by 104
Update on RAAS Modulation for the Treatment of Diabetic Cardiovascular Disease
Bernardi, S., Michelli, A., Zuolo, G., Candido, R., & Fabris, B. (2016) · Journal of Diabetes Research · doi:10.1155/2016/8917578 · Cited by 103
Zou, C., Liu, X., Sang, Y., Wang, B., & Liang, J. (2019) · Medicine · doi:10.1097/md.0000000000018245 · Cited by 103
GLP-1a: Going beyond Traditional Use
Laurindo, L. F., Barbalho, S. M., Guiguer, E. L., da Silva Soares de Souza, M., de Souza, G. A., Fidalgo, T. M., Araújo, A. C., de Souza Gonzaga, H. F., de Bortoli Teixeira, D., de Oliveira Silva Ullmann, T., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020739 · Cited by 102
Free Fatty Acids and Insulin Resistance during Pregnancy
Sivan, E., Homko, C. J., Whittaker, P. G., Reece, E. A., Chen, X., & Boden, G. H. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.7.4927 · Cited by 102
Metformin Improves Peripheral Insulin Sensitivity in Youth With Type 1 Diabetes
Cree-Green, M., Bergman, B. C., Cengiz, E., Fox, L. A., Hannon, T. S., Miller, K., Nathan, B., Pyle, L., Kahn, D., Tansey, M., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00129 · Cited by 101
Szymczak-Pajor, I., Wenclewska, S., & Śliwińska, A. (2022) · Pharmaceuticals · doi:10.3390/ph15070810 · Cited by 101
Yaribeygi, H., Sathyapalan, T., Maleki, M., Jamialahmadi, T., & Sahebkar, A. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.117090 · Cited by 99
Adropin’s Role in Energy Homeostasis and Metabolic Disorders
Ali, I. I., D’Souza, C. M., Singh, J., & Adeghate, E. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158318 · Cited by 98
Adipose tissue renin–angiotensin–aldosterone system (RAAS) and progression of insulin resistance
Marcus, Y., Shefer, G., & Stern, N. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.06.021 · Cited by 97
Nery, C., Moraes, S. R. A. D., Novaes, K. A., Bezerra, M. A., Silveira, P. V. D. C., & Lemos, A. (2017) · Brazilian Journal of Physical Therapy · doi:10.1016/j.bjpt.2017.06.004 · Cited by 95
Tettamanzi, F., Bagnardi, V., Louca, P., Nogal, A., Monti, G. S., Mambrini, S. P., Lucchetti, E., Maestrini, S., Mazza, S., Rodriguez‐Mateos, A., et al. (2021) · Nutrients · doi:10.3390/nu13124380 · Cited by 92
Apelin and insulin resistance: Another arrow for the quiver?
Xu, S., Tsao, P. S., & Yue, P. (2011) · Journal of Diabetes · doi:10.1111/j.1753-0407.2011.00132.x · Cited by 86
Peter, A., Kovářová, M., Staiger, H., Machann, J., Schick, F., Königsrainer, A., Königsrainer, I., Schleicher, E. D., Fritsche, A., Häring, H., et al. (2017) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00262.2017 · Cited by 83
Hiruma, S., Shigiyama, F., Hisatake, S., Mizumura, S., Shiraga, N., Hori, M., Ikeda, T., Hirose, T., & Kumashiro, N. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01228-3 · Cited by 81
Metadata
- Authors
- Kosmas, C. E., Bousvarou, M. D., Kostara, C. E., Papakonstantinou, E. J., Salamou, E., & Guzman, E.
- Venue
- Journal of International Medical Research
- Publisher
- SAGE Publications
- Published
- 2023-03
- Volume
- 51
- Issue
- 3
- Pages
- 3000605231164548-3000605231164548
- ISSN
- 0300-0605 (ISSN-L)
- 1473-2300
- OpenAlex
- W4361273400
- Cited by
- 385
- References
- 268
- FWCI
- 63.70
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.